[MIA 2.0,综合性喘管理,墨西哥的指南]
Désirée E S Larenas-Linnemann1, Jorge A Jorge A2, Arturo Cortés-Telles3
1Centro de Excelencia en Asma y Alergia Larenas, Hospital Médica Sur, Ciudad de México, México.
Boletin medico del Hospital Infantil de Mexico
|May 26, 2025
概括
更新的墨西哥喘指南,MIA 2.0,包括严重恶化管理. 这些基于证据的建议确保为患者提供当前的局部喘护理.
科学领域:
- 肺部病理学 肺部病理学
- 过敏学 过敏学
- 临床实践指南 临床实践指南
背景情况:
- 墨西哥最初的综合性喘管理 (MIA) 准则于2020年建立,基于国际标准.
- 自最初的指导方针制定以来,喘概念和治疗的重大进展已经发生.
研究的目的:
- 制定MIA指南的更新版本,称为MIA 2.0.
- 确保新的指导方针强烈基于证据.
- 将严重喘恶化管理纳入更新的指南.
主要方法:
- 在开发MIA 2.0.0时使用了ADAPTE方法.
- 成立了一个多学科的指导方针开发小组,包括一个核心专家团队和16个机构的代表.
- 使用AGREE-II标准选择了国际指南 (GINA 2024,GEMA 5.4,BTS/SIGN 2024,澳大利亚喘手册2021) 作为参考.
- 在诊断,治疗步骤1-4,严重喘和恶化方面制定了关键的临床问题.
- 为了在开发小组中达成共识,采用了德尔菲进程.
主要成果:
- 对临床问题的答案是根据参考指南的证据制定的,考虑了安全性,成本和墨西哥的当地适用性.
- 德尔菲进程促进了MIA 2.0开发小组的调整和共识建设.
- 由此产生的文件包含了数字和算法,用于喘管理,包括针对墨西哥量身定制的恶化治疗.
结论:
- MIA 2.0为墨西哥的喘管理提供了一个全面的,最新的框架.
- 该指南纳入了最新的证据,并解决了严重的喘恶化.
- 协作开发确保了指导方针的相关性,并被各种医学协会广泛接受.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:20Asthma: Pathogenesis and Management
628
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
628
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
503
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
503
01:24Asthma-III: Symptoms and Complications
2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
336
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
336